{"Title": ["Integra LifeSciences Holdings (IART) Shares Cross Above 200 DMA", "Integra Lifesciences Holdings Corp (IART) Q1 2020 Earnings Call Transcript", "Integra LifeSciences Posts Lower Q1 Profit", "Analysts Expect IWD Will Reach $127", "Noteworthy Friday Option Activity: FLR, IART, TTWO", "Integra Lifesciences Holdings Corp (IART) Q4 2019 Earnings Call Transcript", "Integra LifeSciences Q4 Profit Tops View, But Revenues Miss", "Integra LifeSciences Holdings Enters Oversold Territory (IART)", "Integra LifeSciences Holdings (IART) Shares Cross Above 200 DMA", "First Week of IART February 2020 Options Trading", "IART Crosses Below Key Moving Average Level", "Commit To Purchase Integra LifeSciences Holdings Corp At $60, Earn 14.9% Annualized Using Options", "Integra Lifesciences Holdings Corp (IART) Q3 2019 Earnings Call Transcript", "Integra LifeSciences Holdings Reaches Analyst Target Price", "6 Top Gainers In Healthcare Sector (GHDX, THC, IART\u2026)", "Integra Lifesciences Holdings Corp (IART) Q2 2019 Earnings Call Transcript", "Integra LifeSciences Holdings (IART) Shares Cross Below 200 DMA", "Bullish Two Hundred Day Moving Average Cross - IART", "EQWM's Holdings Imply 16% Gain Potential", "Relative Strength Alert For Integra LifeSciences Holdings", "Integra Lifesciences Holdings Corp (IART) Q1 2019 Earnings Call Transcript", "Oversold Conditions For Integra LifeSciences Holdings (IART)", "Why Is Integra (IART) Down 0.5% Since Last Earnings Report?", "Insiders Bullish on Certain Holdings of MDYG", "Integra LifeSciences Raises FY19 Adj. EPS Outlook, Q2 Profit Surges", "Integra gets FDA warning letter for Boston plant", "Commit To Buy Integra LifeSciences Holdings Corp At $55, Earn 14.3% Annualized Using Options", "Integra Rides on Channel Expansion Strategy, New Alliances", "Integra's (IART) Q4 Earnings and Revenues Beat Estimates", "Integra LifeSciences (IART) Q4 Earnings and Revenues Top Estimates", "Integra Lifesciences Holdings Corp (IART) Q4 2018 Earnings Conference Call Transcript", "Health Care Sector Update for 02/21/2019: ZSAN,IART,NUVA,JNJ", "Integra's Duragen Secures Japanese Nod to Drive Global Growth", "Integra gets FDA warning letter for Boston plant", "Integra (IART) Rises 5% on Robust Preliminary Q4 Results", "Integra LifeSciences Sees Q4 Revenue At Higher End Of Prior Guidance", "Integra Rides on Global Prospects, Hurt by Escalating Costs", "Integra (IART) Down 2.2% Since Last Earnings Report: Can It Rebound?", "Integra's (IART) Margin Pressure Hurts, Global Prospects High", "Health Care Sector Update for 02/21/2019: IART,NUVA,JNJ", "Integra LifeSciences Holdings Becomes Oversold (IART)", "Notable Two Hundred Day Moving Average Cross - IART", "Integra LifeSciences (IART) Matches Q3 Earnings Estimates", "Integra LifeSciences (IART) Q3 Earnings Preview: What to Watch Ahead of the Release", "IART Crosses Above Average Analyst Target", "Integra Lifesciences Picked for Healogics iSupply Program", "Thursday's ETF with Unusual Volume: IYH", "Integra (IART) Q3 Earnings Meet Estimates, Revenue View Dips", "Why Is Integra (IART) Down 2.7% Since Last Earnings Report?", "Integra LifeSciences Codman Arm Strong, Competition Rife", "IART Crosses Above Average Analyst Target", "Notable Tuesday Option Activity: NSC, NYT, IART", "Integra LifeSciences Global Prospects Solid, Competition Rife", "Here's Why You Should Buy Integra LifeSciences (IART) Stock", "After Hours Most Active for Jun 4, 2018 : NAVI, WR, GXP, IART, TRI, NRG, RGEN, RBS, F, MSFT, TMUS, AMAT", "First Week of IART October 19th Options Trading", "Financial Sector Update for 06/01/2018: IBTX,AMBC,IART,GXP,NMR,DB", "Notable ETF Inflow Detected - IJR, CHE, HAE, IART", "Why Is Integra LifeSciences (IART) Up 8.5% Since Its Last Earnings Report?", "Should You Invest in the PowerShares S&P SmallCap Health Care Portfolio (PSCH)?", "Ligand Pharmaceuticals (LGND) Hits a 52-Week High, Can the Run Continue?", "Notable ETF Inflow Detected - IJR, CHE, HAE, IART", "Integra LifeSciences (IART) Tops on Q1 Earnings, '18 View Up", "Financial Sector Update for 06/01/2018: AMBC, IART, NMR, GXP, DB", "Financial Sector Update for 06/01/2018: IBTX,AMBC,IART,GXP,NMR,DB", "Notable ETF Inflow Detected - IJR, CHE, HAE, IART", "Why Is Integra LifeSciences (IART) Up 8.5% Since Its Last Earnings Report?", "Integra LifeSciences (IART) Beats on Q4 Earnings & Revenues", "Health Care Sector Update for 02/27/2018: MNK, IART, AMRN, PRGO. EXEL", "Health Care Sector Update for 02/27/2018: IART,PRGO,MNK,AMRN", "Should You Invest in the PowerShares S&P SmallCap Health Care Portfolio (PSCH)?", "IART Crosses Above Average Analyst Target", "Why Is Integra LifeSciences (IART) Up 3.6% Since Its Last Earnings Report?", "Integra LifeSciences Holdings Reaches Analyst Target Price", "Integra LifeSciences Banks on CSS Segment, Competition Rife", "Integra LifeSciences Holdings Reaches Analyst Target Price", "Integra LifeSciences Estimates Strong Revenue Figures for Q4", "IART Makes Notable Cross Below Critical Moving Average", "Can Segmental Strength Drive Integra's (IART) Q4 Earnings?", "Thursday 11/2 Insider Buying Report: IART, BHBK", "Integra Gains on Global Growth, Hurricanes Hamper Business", "Integra LifeSciences Holdings is Now Oversold (IART)", "Integra LifeSciences (IART) Misses on Q3 Earnings & Revenues", "Integra Lifesciences Hld Earns RS Rating Upgrade", "Quest Diagnostics (DGX) Beats Earnings in Q3, Updates View", "Abbott (ABT) Exceeds Q3 Earnings, '17 Guidance Narrowed", "Integra (IART) Up 1.8% Since Earnings Report: Can It Continue?", "Integra's (IART) Revize/Revize-X Boosts Tissue Technology Arm", "Integra Rides High on Product Launches, Competition Rife", "Integra LifeSciences' SurgiMend PRS Meshed Boosts ADM Line", "Integra Closes Codman Buyout, Strengthens Neurosurgery Arm", "11.0% of VTWG Holdings Seeing Recent Insider Buys", "Integra Divests Assets to Natus, Paves Way for Codman Buyout", "Integra LifeSciences Holdings Enters Oversold Territory (IART)", "3 Plastic & Reconstructive Surgery Stocks Looking Good", "Integra's (IART) Revize/Revize-X Boosts Tissue Technology Arm", "Integra Rides High on Product Launches, Competition Rife", "Integra LifeSciences' SurgiMend PRS Meshed Boosts ADM Line", "Integra Closes Codman Buyout, Strengthens Neurosurgery Arm", "Integra LifeSciences (IART) Misses Q1 Earnings, Retains View", "Integra LifeSciences' Stock Split: Why It Accomplished Nothing", "Integra LifeSciences (IART) Q2 Earnings Meet, Revenues Miss", "Integra LifeSciences Expands Cadence System Commercially", "Integra (IART) Titan Reverse Launch Expands Extremity Line", "Integra (IART) Posts In-Line Q4 Earnings, Issues 2017 View", "Health Care Sector Update for 02/15/2017: IART", "Company News for January 12, 2017", "Midday Update: Wall Street Whipsawed as Trump Criticizes Drug Cos, Praises Auto Makers, Leaves out Fiscal Stimulus Talk", "Mid-Morning Market Update: Markets Mostly Higher; SUPERVALU Earnings Miss Views", "Integra LifeSciences (IART) Q1 Earnings: A Beat in Store?", "Health Care Sector Update for 01/11/2017: SHPG,DSCI,IART,NVDQ", "Mid-Afternoon Market Update: Derma Sciences Climbs On Acquisition News; Novadaq Shares Plunge", "Health Care Sector Update for 01/11/2017: SYK,DSCI,IART,NVDQ", "First Week of IART February 2017 Options Trading", "After Hours Most Active for Nov 15, 2016 : QQQ, BAC, GE, SMFG, HES, MSFT, CVX, RF, FB, GRPN, AAPL, IART", "Integra (IART) Catches Eye: Stock Adds 6% in Session", "Integra (IART) Posts Q3 Earnings & Sales Beat, Margins Up", "Integra LifeSciences at 52-Week High on Deals, View Update", "Health Care Sector Update for 01/11/2017: SHPG,DSCI,IART,NVDQ", "Mid-Afternoon Market Update: Derma Sciences Climbs On Acquisition News; Novadaq Shares Plunge", "Health Care Sector Update for 01/11/2017: SYK,DSCI,IART,NVDQ", "5 Medtech Stocks to Watch Out for in 2H16", "Why the P/S Ratio is My Favorite Valuation Metric", "Integra LifeSciences at 52-Week High on Solid Q1 Results", "Integra Life Sciences Forges Ahead with Expansion Plans", "Integra LifeSciences Holdings Corp is Now Oversold", "Integra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty", "Health Care Sector Update for 05/11/2016: IART", "Integra (IART) Beats on Q1 Earnings, Grows Organically", "Integra LifeSciences Global Prospects Bright, Risks Remain", "Integra Lifesciences Tops Q4 Earnings, Revenues Up Y/Y", "Oversold Conditions For Integra LifeSciences Holdings (IART)", "Integra Strong on International Growth; US Spine Bothers", "Integra (IART): Strong Revenue Growth on Global Prospects", "Integra LifeSciences Tops Q3 Earnings, Revenues; View Up", "Integra (IART) Hopeful on Spine Spin-Off amid Global Woes", "Integra Faces Multiple Headwinds, SeaSpine Spin-off Strong", "Integra Closes TEI Buyout to Grow in Regenerative Wound Care", "Integra's Acquisitions to Buoy Growth in '15, Currency Woes Stay", "Integra Tops Earnings & Revenues, Guides Low on Spine Sale - Analyst Blog", "Mid-Morning Market Update: Markets Edge Higher; Centene To Acquire Health Net For $6.3B", "Should You Retain Integra LifeSciences (IART) in Your Portfolio?", "Integra to Acquire TEI, Expand in Regenerative Wound Care - Analyst Blog", "Is Integra LifeSciences (IART) an Incredible Growth Stock? 3 Reasons Why It Will Be Tough to Beat - Tale of the Tape", "Integra LifeSciences Tops Q1 Earnings, Revenues; View Up - Analyst Blog", "Health Care Sector Update for 05/01/2015: IART,NKTR,TLOG", "Integra (IART) Rides High on Solid Q4, DuraSeal Product Line - Analyst Blog", "Integra Lifesciences Tops Q4 Earnings, Revenues; Up Y/Y - Analyst Blog", "Integra LifeSciences Hits 52-Week High on Portfolio Strength - Analyst Blog", "Integra LifeSciences (IART) Closes SeaSpine Spin-Off - Analyst Blog", "Integra to Acquire TEI, Expand in Regenerative Wound Care - Analyst Blog", "Is Integra LifeSciences (IART) an Incredible Growth Stock? 3 Reasons Why It Will Be Tough to Beat - Tale of the Tape", "Integra LifeSciences Tops Q1 Earnings, Revenues; View Up - Analyst Blog", "Health Care Sector Update for 05/01/2015: IART,NKTR,TLOG", "Integra Freedom Wrist's Commercial Availability Falls Flat - Analyst Blog", "Integra to Buy Medtronic's MicroFrance, Xomed; Shares Up - Analyst Blog", "Integra Poised on Impressive Duraseal Product Line, Solid Q2 - Analyst Blog", "Integra Lifesciences Up on Launch of Bilayer Skin Product - Analyst Blog", "Integra Upbeat on DuraSeal Acquisition despite Tepid Q1 - Analyst Blog", "Integra LifeSciences (IART): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report", "Integra Lifesciences Down to Sell - Analyst Blog", "Integra LifeSciences, Premier Ink 3-Year Purchase Deal - Analyst Blog", "Integra Lifesciences Down to Sell on Poor Q1 Segment Show - Analyst Blog", "Notable Two Hundred Day Moving Average Cross - IART", "FDA OKs Integra's Camino Flex Ventricular Catheter - Analyst Blog", "Integra LifeSciences Tops Q2 Earnings, Revenues, Shares Up - Analyst Blog", "First Laminoplasty Implant at Integra - Analyst Blog", "Integra Lifesciences Holdings Corp (IART) Enters Overbought Territory - Tale of the Tape", "IART Publishes Positive Study Results - Analyst Blog", "Is This the Top for Integra Lifesciences Holdings Corp. (IART) - Tale of the Tape", "IART Accomplishes Shoulder Implant - Analyst Blog", "Integra Receives Go-Ahead in N.J. - Analyst Blog", "Integra Tops Earnings, Revs Lag - Analyst Blog", "Integra LifeSciences Introduces Wound Matrix - Analyst Blog", "Bear of the Day: Integra LifeSciences (IART) - Bear of the Day", "Disappointing 1Q Earnings for IART - Analyst Blog", "Product Recall Plagues Integra - Analyst Blog", "Integra's Second Cobalt Chrome Rod - Analyst Blog", "FDA Nod for Integra's Extremity Offer - Analyst Blog", "Integra Strong on Balanced Growth - Analyst Blog", "Accuray's Outlook Disappoints - Analyst Blog", "Integra Grows European Portfolio - Analyst Blog", "Accuray Misses Ests, Loss Widens - Analyst Blog", "FDA Clears Accuray's CyberKnife M6 - Analyst Blog", "Integra Beats on EPS, Misses Rev - Analyst Blog", "Accuray Reiterated at Neutral - Analyst Blog", "Accuray Misses Ests, Posts Loss - Analyst Blog", "Encouraging 2Q for Integra - Analyst Blog", "Integra's New PIP Fixation Device - Analyst Blog", "Accuray Down to Underperform - Analyst Blog", "FDA Nod for Integra Spine - Analyst Blog", "Integra Expands in Europe - Analyst Blog", "Integra Launches New Vet Products - Analyst Blog", "Integra Beats on EPS, Revs In Line - Analyst Blog", "Integra's New Extremity Offering - Analyst Blog", "Integra's Prelim Results Disappoint - Analyst Blog", "Medical Breakthrough: Successful Stem Cell Transplant in Sweden", "Integra Beats, Ups EPS Guidance - Analyst Blog", "Mid-Day Update: Stocks Pare Modest Early Gains Despite Upbeat Home Sales", "Opening View: DJIA Leaves April Behind, Looks to Higher Ground in May", "Stocks Downshift Into Red; Earnings, Home Sales Data Support Erodes"], "Elapsed Time": ["JUN 5, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 5, 2020", "FEB 28, 2020", "FEB 19, 2020", "FEB 19, 2020", "JAN 27, 2020", "JUN 5, 2020", "DEC 24, 2019", "DEC 20, 2019", "DEC 13, 2019", "OCT 25, 2019", "JUL 25, 2019", "JUL 24, 2019", "JUL 24, 2019", "JAN 23, 2020", "JUN 24, 2019", "JUN 10, 2019", "MAY 28, 2019", "APR 24, 2019", "APR 17, 2019", "MAR 23, 2019", "MAR 22, 2019", "JUL 24, 2019", "MAR 11, 2019", "FEB 28, 2019", "FEB 28, 2019", "FEB 26, 2019", "FEB 21, 2019", "FEB 21, 2019", "FEB 21, 2019", "MAR 15, 2019", "MAR 11, 2019", "JAN 9, 2019", "JAN 8, 2019", "DEC 24, 2018", "NOV 30, 2018", "NOV 28, 2018", "FEB 21, 2019", "OCT 31, 2018", "OCT 31, 2018", "OCT 31, 2018", "OCT 24, 2018", "SEP 12, 2018", "SEP 11, 2018", "SEP 6, 2018", "NOV 1, 2018", "AUG 24, 2018", "AUG 14, 2018", "AUG 3, 2018", "JUL 24, 2018", "JUN 27, 2018", "JUN 22, 2018", "JUN 4, 2018", "AUG 28, 2018", "JUN 1, 2018", "MAY 31, 2018", "MAY 25, 2018", "MAY 25, 2018", "MAY 21, 2018", "MAY 15, 2018", "APR 26, 2018", "JUN 1, 2018", "JUN 1, 2018", "MAY 31, 2018", "MAY 25, 2018", "FEB 28, 2018", "FEB 27, 2018", "FEB 27, 2018", "APR 18, 2018", "APR 13, 2018", "MAR 29, 2018", "MAR 12, 2018", "FEB 2, 2018", "JAN 23, 2018", "JAN 12, 2018", "DEC 29, 2017", "FEB 26, 2018", "NOV 2, 2017", "NOV 2, 2017", "OCT 27, 2017", "OCT 27, 2017", "OCT 26, 2017", "OCT 19, 2017", "OCT 18, 2017", "NOV 27, 2017", "OCT 9, 2017", "OCT 5, 2017", "OCT 4, 2017", "OCT 3, 2017", "SEP 20, 2017", "SEP 13, 2017", "AUG 1, 2017", "OCT 11, 2017", "OCT 9, 2017", "OCT 5, 2017", "OCT 4, 2017", "OCT 3, 2017", "APR 27, 2017", "APR 15, 2017", "JUL 27, 2017", "MAR 29, 2017", "MAR 16, 2017", "FEB 27, 2017", "FEB 15, 2017", "JAN 12, 2017", "JAN 11, 2017", "JAN 11, 2017", "APR 13, 2017", "JAN 11, 2017", "JAN 11, 2017", "JAN 11, 2017", "DEC 21, 2016", "NOV 15, 2016", "OCT 31, 2016", "OCT 28, 2016", "JAN 11, 2017", "JAN 11, 2017", "JAN 11, 2017", "JAN 11, 2017", "JUL 5, 2016", "JUL 5, 2016", "JUL 4, 2016", "JUN 28, 2016", "OCT 27, 2016", "MAY 24, 2016", "MAY 11, 2016", "APR 28, 2016", "MAR 4, 2016", "FEB 26, 2016", "FEB 5, 2016", "JAN 11, 2016", "JUN 1, 2016", "NOV 4, 2015", "OCT 2, 2015", "SEP 10, 2015", "AUG 14, 2015", "AUG 14, 2015", "AUG 3, 2015", "JUL 2, 2015", "DEC 9, 2015", "JUN 30, 2015", "MAY 18, 2015", "MAY 4, 2015", "MAY 1, 2015", "MAR 18, 2015", "FEB 25, 2015", "DEC 24, 2014", "JUL 2, 2015", "JUN 30, 2015", "MAY 18, 2015", "MAY 4, 2015", "MAY 1, 2015", "SEP 23, 2014", "SEP 22, 2014", "SEP 18, 2014", "DEC 19, 2014", "JUL 7, 2014", "JUL 3, 2014", "JUN 30, 2014", "JUN 16, 2014", "JUN 10, 2014", "JUN 2, 2014", "APR 7, 2014", "AUG 7, 2014", "MAR 14, 2014", "JAN 9, 2014", "DEC 16, 2013", "OCT 14, 2013", "SEP 24, 2013", "AUG 16, 2013", "AUG 6, 2013", "MAR 28, 2014", "JUN 3, 2013", "MAY 10, 2013", "APR 11, 2013", "MAR 26, 2013", "MAR 22, 2013", "FEB 26, 2013", "JAN 7, 2013", "JUN 27, 2013", "NOV 9, 2012", "NOV 5, 2012", "OCT 29, 2012", "SEP 24, 2012", "SEP 7, 2012", "JUL 27, 2012", "JUN 22, 2012", "NOV 28, 2012", "APR 20, 2012", "MAR 28, 2012", "MAR 21, 2012", "FEB 24, 2012", "FEB 10, 2012", "JAN 6, 2012", "JUL 8, 2011", "APR 26, 2012", "MAY 24, 2011", "MAY 3, 2010", "MAY 24, 2011"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/integra-lifesciences-holdings-iart-shares-cross-above-200-dma-2020-06-05", "https://www.nasdaq.com/articles/integra-lifesciences-holdings-corp-iart-q1-2020-earnings-call-transcript-2020-05-08", "https://www.nasdaq.com/articles/integra-lifesciences-posts-lower-q1-profit-2020-05-07", "https://www.nasdaq.com/articles/analysts-expect-iwd-will-reach-%24127-2020-05-05", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity%3A-flr-iart-ttwo-2020-02-28", "https://www.nasdaq.com/articles/integra-lifesciences-holdings-corp-iart-q4-2019-earnings-call-transcript-2020-02-19", "https://www.nasdaq.com/articles/integra-lifesciences-q4-profit-tops-view-but-revenues-miss-2020-02-19", "https://www.nasdaq.com/articles/integra-lifesciences-holdings-enters-oversold-territory-iart-2020-01-27", "https://www.nasdaq.com/articles/integra-lifesciences-holdings-iart-shares-cross-above-200-dma-2020-06-05", "https://www.nasdaq.com/articles/first-week-of-iart-february-2020-options-trading-2019-12-24", "https://www.nasdaq.com/articles/iart-crosses-below-key-moving-average-level-2019-12-20", "https://www.nasdaq.com/articles/commit-to-purchase-integra-lifesciences-holdings-corp-at-%2460-earn-14.9-annualized-using", "https://www.nasdaq.com/articles/integra-lifesciences-holdings-corp-iart-q3-2019-earnings-call-transcript-2019-10-25", "https://www.nasdaq.com/articles/integra-lifesciences-holdings-reaches-analyst-target-price-2019-07-25", "https://www.nasdaq.com/articles/6-top-gainers-in-healthcare-sector-ghdx-thc-iart...-2019-07-24", "https://www.nasdaq.com/articles/integra-lifesciences-holdings-corp-iart-q2-2019-earnings-call-transcript-2019-07-24", "https://www.nasdaq.com/articles/integra-lifesciences-holdings-iart-shares-cross-below-200-dma-2020-01-23", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-iart-2019-06-24", "https://www.nasdaq.com/articles/eqwms-holdings-imply-16-gain-potential-2019-06-10", "https://www.nasdaq.com/articles/relative-strength-alert-integra-lifesciences-holdings-2019-05-28", "https://www.nasdaq.com/articles/integra-lifesciences-holdings-corp-iart-q1-2019-earnings-call-transcript-2019-04-24", "https://www.nasdaq.com/articles/oversold-conditions-integra-lifesciences-holdings-iart-2019-04-17", "https://www.nasdaq.com/articles/why-is-integra-iart-down-0.5-since-last-earnings-report-2019-03-23", "https://www.nasdaq.com/articles/insiders-bullish-certain-holdings-mdyg-2019-03-22", "https://www.nasdaq.com/articles/integra-lifesciences-raises-fy19-adj.-eps-outlook-q2-profit-surges-2019-07-24", "https://www.nasdaq.com/articles/integra-gets-fda-warning-letter-boston-plant-2019-03-11", "https://www.nasdaq.com/articles/commit-buy-integra-lifesciences-holdings-corp-55-earn-143-annualized-using-options-2019-02", "https://www.nasdaq.com/articles/integra-rides-on-channel-expansion-strategy-new-alliances-2019-02-28", "https://www.nasdaq.com/articles/integras-iart-q4-earnings-and-revenues-beat-estimates-2019-02-26", "https://www.nasdaq.com/articles/integra-lifesciences-iart-q4-earnings-and-revenues-top-estimates-2019-02-21", "https://www.nasdaq.com/articles/integra-lifesciences-holdings-corp-iart-q4-2018-earnings-conference-call-transcript-2019", "https://www.nasdaq.com/articles/health-care-sector-update-02212019-zsaniartnuvajnj-2019-02-21", "https://www.nasdaq.com/articles/integras-duragen-secures-japanese-nod-to-drive-global-growth-2019-03-15", "https://www.nasdaq.com/articles/integra-gets-fda-warning-letter-boston-plant-2019-03-11", "https://www.nasdaq.com/articles/integra-iart-rises-5-on-robust-preliminary-q4-results-2019-01-09", "https://www.nasdaq.com/articles/integra-lifesciences-sees-q4-revenue-higher-end-prior-guidance-2019-01-08", "https://www.nasdaq.com/articles/integra-rides-on-global-prospects-hurt-by-escalating-costs-2018-12-24", "https://www.nasdaq.com/articles/integra-iart-down-2.2-since-last-earnings-report%3A-can-it-rebound-2018-11-30", "https://www.nasdaq.com/articles/integras-iart-margin-pressure-hurts-global-prospects-high-2018-11-28", "https://www.nasdaq.com/articles/health-care-sector-update-02212019-iartnuvajnj-2019-02-21", "https://www.nasdaq.com/articles/integra-lifesciences-holdings-becomes-oversold-iart-2018-10-31", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-iart-2018-10-31", "https://www.nasdaq.com/articles/integra-lifesciences-iart-matches-q3-earnings-estimates-2018-10-31", "https://www.nasdaq.com/articles/integra-lifesciences-iart-q3-earnings-preview%3A-what-to-watch-ahead-of-the-release-2018-10", "https://www.nasdaq.com/articles/iart-crosses-above-average-analyst-target-2018-09-12", "https://www.nasdaq.com/articles/integra-lifesciences-picked-for-healogics-isupply-program-2018-09-11", "https://www.nasdaq.com/articles/thursdays-etf-unusual-volume-iyh-2018-09-06", "https://www.nasdaq.com/articles/integra-iart-q3-earnings-meet-estimates-revenue-view-dips-2018-11-01", "https://www.nasdaq.com/articles/why-is-integra-iart-down-2.7-since-last-earnings-report-2018-08-24", "https://www.nasdaq.com/articles/integra-lifesciences-codman-arm-strong-competition-rife-2018-08-14", "https://www.nasdaq.com/articles/iart-crosses-above-average-analyst-target-2018-08-03", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-nsc-nyt-iart-2018-07-24", "https://www.nasdaq.com/articles/integra-lifesciences-global-prospects-solid-competition-rife-2018-06-27", "https://www.nasdaq.com/articles/heres-why-you-should-buy-integra-lifesciences-iart-stock-2018-06-22", "https://www.nasdaq.com/articles/after-hours-most-active-jun-4-2018-navi-wr-gxp-iart-tri-nrg-rgen-rbs-f-msft-tmus-amat-2018", "https://www.nasdaq.com/articles/first-week-iart-october-19th-options-trading-2018-08-28", "https://www.nasdaq.com/articles/financial-sector-update-06012018-ibtxambciartgxpnmrdb-2018-06-01", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-ijr-che-hae-iart-2018-05-31", "https://www.nasdaq.com/articles/why-is-integra-lifesciences-iart-up-8.5-since-its-last-earnings-report-2018-05-25", "https://www.nasdaq.com/articles/should-you-invest-in-the-powershares-sp-smallcap-health-care-portfolio-psch-2018-05-25", "https://www.nasdaq.com/articles/ligand-pharmaceuticals-lgnd-hits-a-52-week-high-can-the-run-continue-2018-05-21", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-ijr-che-hae-iart-2018-05-15", "https://www.nasdaq.com/articles/integra-lifesciences-iart-tops-on-q1-earnings-18-view-up-2018-04-26", "https://www.nasdaq.com/articles/financial-sector-update-06012018-ambc-iart-nmr-gxp-db-2018-06-01", "https://www.nasdaq.com/articles/financial-sector-update-06012018-ibtxambciartgxpnmrdb-2018-06-01", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-ijr-che-hae-iart-2018-05-31", "https://www.nasdaq.com/articles/why-is-integra-lifesciences-iart-up-8.5-since-its-last-earnings-report-2018-05-25", "https://www.nasdaq.com/articles/integra-lifesciences-iart-beats-on-q4-earnings-revenues-2018-02-28", "https://www.nasdaq.com/articles/health-care-sector-update-02272018-mnk-iart-amrn-prgo-exel-2018-02-27", "https://www.nasdaq.com/articles/health-care-sector-update-02272018-iartprgomnkamrn-2018-02-27", "https://www.nasdaq.com/articles/should-you-invest-in-the-powershares-sp-smallcap-health-care-portfolio-psch-2018-04-18", "https://www.nasdaq.com/articles/iart-crosses-above-average-analyst-target-2018-04-13", "https://www.nasdaq.com/articles/why-is-integra-lifesciences-iart-up-3.6-since-its-last-earnings-report-2018-03-29", "https://www.nasdaq.com/articles/integra-lifesciences-holdings-reaches-analyst-target-price-2018-03-12", "https://www.nasdaq.com/articles/integra-lifesciences-global-prospects-solid-competition-rife-2018-02-02", "https://www.nasdaq.com/articles/integra-lifesciences-holdings-reaches-analyst-target-price-2018-01-23", "https://www.nasdaq.com/articles/integra-lifesciences-estimates-strong-revenue-figures-for-q4-2018-01-12", "https://www.nasdaq.com/articles/iart-makes-notable-cross-below-critical-moving-average-2017-12-29", "https://www.nasdaq.com/articles/can-segmental-strength-drive-integras-iart-q4-earnings-2018-02-26", "https://www.nasdaq.com/articles/thursday-112-insider-buying-report-iart-bhbk-2017-11-02", "https://www.nasdaq.com/articles/integra-gains-on-global-growth-hurricanes-hamper-business-2017-11-02", "https://www.nasdaq.com/articles/integra-lifesciences-holdings-now-oversold-iart-2017-10-27", "https://www.nasdaq.com/articles/integra-lifesciences-iart-misses-on-q3-earnings-revenues-2017-10-27", "https://www.nasdaq.com/articles/integra-lifesciences-hld-earns-rs-rating-upgrade-2017-10-26", "https://www.nasdaq.com/articles/quest-diagnostics-dgx-beats-earnings-in-q3-updates-view-2017-10-19", "https://www.nasdaq.com/articles/abbott-abt-exceeds-q3-earnings-17-guidance-narrowed-2017-10-18", "https://www.nasdaq.com/articles/integra-iart-up-1.8-since-earnings-report%3A-can-it-continue-2017-11-27", "https://www.nasdaq.com/articles/integras-iart-revize-revize-x-boosts-tissue-technology-arm-2017-10-09", "https://www.nasdaq.com/articles/integra-rides-high-on-product-launches-competition-rife-2017-10-05", "https://www.nasdaq.com/articles/integra-lifesciences-surgimend-prs-meshed-boosts-adm-line-2017-10-04", "https://www.nasdaq.com/articles/integra-closes-codman-buyout-strengthens-neurosurgery-arm-2017-10-03", "https://www.nasdaq.com/articles/110-vtwg-holdings-seeing-recent-insider-buys-2017-09-20", "https://www.nasdaq.com/articles/integra-divests-assets-to-natus-paves-way-for-codman-buyout-2017-09-13", "https://www.nasdaq.com/articles/integra-lifesciences-holdings-enters-oversold-territory-iart-2017-08-01", "https://www.nasdaq.com/articles/3-plastic-reconstructive-surgery-stocks-looking-good-2017-10-11", "https://www.nasdaq.com/articles/integras-iart-revize-revize-x-boosts-tissue-technology-arm-2017-10-09", "https://www.nasdaq.com/articles/integra-rides-high-on-product-launches-competition-rife-2017-10-05", "https://www.nasdaq.com/articles/integra-lifesciences-surgimend-prs-meshed-boosts-adm-line-2017-10-04", "https://www.nasdaq.com/articles/integra-closes-codman-buyout-strengthens-neurosurgery-arm-2017-10-03", "https://www.nasdaq.com/articles/integra-lifesciences-iart-misses-q1-earnings-retains-view-2017-04-27", "https://www.nasdaq.com/articles/integra-lifesciences-stock-split-why-it-accomplished-nothing-2017-04-15", "https://www.nasdaq.com/articles/integra-lifesciences-iart-q2-earnings-meet-revenues-miss-2017-07-27", "https://www.nasdaq.com/articles/integra-lifesciences-expands-cadence-system-commercially-2017-03-29", "https://www.nasdaq.com/articles/integra-iart-titan-reverse-launch-expands-extremity-line-2017-03-16", "https://www.nasdaq.com/articles/integra-iart-posts-in-line-q4-earnings-issues-2017-view-2017-02-27", "https://www.nasdaq.com/articles/health-care-sector-update-02152017-iart-2017-02-15", "https://www.nasdaq.com/articles/company-news-for-january-12-2017-2017-01-12", "https://www.nasdaq.com/articles/midday-update-wall-street-whipsawed-trump-criticizes-drug-cos-praises-auto-makers-leaves", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mostly-higher-supervalu-earnings-miss-views-2017-01-11", "https://www.nasdaq.com/articles/integra-lifesciences-iart-q1-earnings%3A-a-beat-in-store-2017-04-13", "https://www.nasdaq.com/articles/health-care-sector-update-01112017-shpgdsciiartnvdq-2017-01-11", "https://www.nasdaq.com/articles/mid-afternoon-market-update-derma-sciences-climbs-acquisition-news-novadaq-shares-plunge", "https://www.nasdaq.com/articles/health-care-sector-update-01112017-sykdsciiartnvdq-2017-01-11", "https://www.nasdaq.com/articles/first-week-iart-february-2017-options-trading-2016-12-21", "https://www.nasdaq.com/articles/after-hours-most-active-nov-15-2016-qqq-bac-ge-smfg-hes-msft-cvx-rf-fb-grpn-aapl-iart-2016", "https://www.nasdaq.com/articles/integra-iart-catches-eye%3A-stock-adds-6-in-session-2016-10-31", "https://www.nasdaq.com/articles/integra-iart-posts-q3-earnings-sales-beat-margins-up-2016-10-28", "https://www.nasdaq.com/articles/integra-lifesciences-at-52-week-high-on-deals-view-update-2017-01-11", "https://www.nasdaq.com/articles/health-care-sector-update-01112017-shpgdsciiartnvdq-2017-01-11", "https://www.nasdaq.com/articles/mid-afternoon-market-update-derma-sciences-climbs-acquisition-news-novadaq-shares-plunge", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-beacon-roofing-supply-core-mark-hni-integra-lifesciences", "https://www.nasdaq.com/articles/5-medtech-stocks-to-watch-out-for-in-2h16-2016-07-05", "https://www.nasdaq.com/articles/why-ps-ratio-my-favorite-valuation-metric-2016-07-05", "https://www.nasdaq.com/articles/integra-lifesciences-at-52-week-high-on-solid-q1-results-2016-07-04", "https://www.nasdaq.com/articles/integra-life-sciences-forges-ahead-with-expansion-plans-2016-06-28", "https://www.nasdaq.com/articles/integra-lifesciences-holdings-corp-now-oversold-2016-10-27", "https://www.nasdaq.com/articles/integra-unveils-fin-lock-glenoid-boosts-shoulder-arthroplasty-2016-05-24", "https://www.nasdaq.com/articles/health-care-sector-update-05112016-iart-2016-05-11", "https://www.nasdaq.com/articles/integra-iart-beats-on-q1-earnings-grows-organically-2016-04-28", "https://www.nasdaq.com/articles/integra-lifesciences-global-prospects-bright-risks-remain-2016-03-04", "https://www.nasdaq.com/articles/integra-lifesciences-tops-q4-earnings-revenues-up-y-y-2016-02-26", "https://www.nasdaq.com/articles/oversold-conditions-integra-lifesciences-holdings-iart-2016-02-05", "https://www.nasdaq.com/articles/integra-strong-on-international-growth-us-spine-bothers-2016-01-11", "https://www.nasdaq.com/articles/integra-iart%3A-strong-revenue-growth-on-global-prospects-2016-06-01", "https://www.nasdaq.com/articles/integra-lifesciences-tops-q3-earnings-revenues-view-up-2015-11-04", "https://www.nasdaq.com/articles/integra-iart-hopeful-on-spine-spin-off-amid-global-woes-2015-10-02", "https://www.nasdaq.com/articles/integra-faces-multiple-headwinds-seaspine-spin-off-strong-2015-09-10", "https://www.nasdaq.com/articles/integra-closes-tei-buyout-to-grow-in-regenerative-wound-care-2015-08-14", "https://www.nasdaq.com/articles/integras-acquisitions-to-buoy-growth-in-15-currency-woes-stay-2015-08-14", "https://www.nasdaq.com/articles/integra-tops-earnings-revenues-guides-low-on-spine-sale-analyst-blog-2015-08-03", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-higher-centene-acquire-health-net-63b-2015-07-02", "https://www.nasdaq.com/articles/should-you-retain-integra-lifesciences-iart-in-your-portfolio-2015-12-09", "https://www.nasdaq.com/articles/integra-to-acquire-tei-expand-in-regenerative-wound-care-analyst-blog-2015-06-30", "https://www.nasdaq.com/articles/is-integra-lifesciences-iart-an-incredible-growth-stock-3-reasons-why-it-will-be-tough-to", "https://www.nasdaq.com/articles/integra-lifesciences-tops-q1-earnings-revenues-view-up-analyst-blog-2015-05-04", "https://www.nasdaq.com/articles/health-care-sector-update-05012015-iartnktrtlog-2015-05-01", "https://www.nasdaq.com/articles/integra-iart-rides-high-on-solid-q4-duraseal-product-line-analyst-blog-2015-03-18", "https://www.nasdaq.com/articles/integra-lifesciences-tops-q4-earnings-revenues-up-y-y-analyst-blog-2015-02-25", "https://www.nasdaq.com/articles/integra-lifesciences-hits-52-week-high-on-portfolio-strength-analyst-blog-2014-12-24", "https://www.nasdaq.com/articles/integra-lifesciences-iart-closes-seaspine-spin-off-analyst-blog-2015-07-02", "https://www.nasdaq.com/articles/integra-to-acquire-tei-expand-in-regenerative-wound-care-analyst-blog-2015-06-30", "https://www.nasdaq.com/articles/is-integra-lifesciences-iart-an-incredible-growth-stock-3-reasons-why-it-will-be-tough-to", "https://www.nasdaq.com/articles/integra-lifesciences-tops-q1-earnings-revenues-view-up-analyst-blog-2015-05-04", "https://www.nasdaq.com/articles/health-care-sector-update-05012015-iartnktrtlog-2015-05-01", "https://www.nasdaq.com/articles/integra-freedom-wrists-commercial-availability-falls-flat-analyst-blog-2014-09-23", "https://www.nasdaq.com/articles/integra-to-buy-medtronics-microfrance-xomed-shares-up-analyst-blog-2014-09-22", "https://www.nasdaq.com/articles/integra-poised-on-impressive-duraseal-product-line-solid-q2-analyst-blog-2014-09-18", "https://www.nasdaq.com/articles/integra-lifesciences-up-on-launch-of-bilayer-skin-product-analyst-blog-2014-12-19", "https://www.nasdaq.com/articles/integra-upbeat-on-duraseal-acquisition-despite-tepid-q1-analyst-blog-2014-07-07", "https://www.nasdaq.com/articles/integra-lifesciences-iart-new-analyst-report-zacks-equity-research-zacks-equity-research", "https://www.nasdaq.com/articles/integra-lifesciences-down-to-sell-analyst-blog-2014-06-30", "https://www.nasdaq.com/articles/integra-lifesciences-premier-ink-3-year-purchase-deal-analyst-blog-2014-06-16", "https://www.nasdaq.com/articles/integra-lifesciences-down-to-sell-on-poor-q1-segment-show-analyst-blog-2014-06-10", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-iart-2014-06-02", "https://www.nasdaq.com/articles/fda-oks-integras-camino-flex-ventricular-catheter-analyst-blog-2014-04-07", "https://www.nasdaq.com/articles/integra-lifesciences-tops-q2-earnings-revenues-shares-up-analyst-blog-2014-08-07", "https://www.nasdaq.com/articles/first-laminoplasty-implant-at-integra-analyst-blog-2014-03-14", "https://www.nasdaq.com/articles/integra-lifesciences-holdings-corp-iart-enters-overbought-territory-tale-of-the-tape-2014", "https://www.nasdaq.com/articles/iart-publishes-positive-study-results-analyst-blog-2013-12-16", "https://www.nasdaq.com/articles/is-this-the-top-for-integra-lifesciences-holdings-corp.-iart-tale-of-the-tape-2013-10-14", "https://www.nasdaq.com/articles/iart-accomplishes-shoulder-implant-analyst-blog-2013-09-24", "https://www.nasdaq.com/articles/integra-receives-go-ahead-in-n.j.-analyst-blog-2013-08-16", "https://www.nasdaq.com/articles/integra-tops-earnings-revs-lag-analyst-blog-2013-08-06", "https://www.nasdaq.com/articles/integra-lifesciences-introduces-wound-matrix-analyst-blog-2014-03-28", "https://www.nasdaq.com/articles/bear-day-integra-lifesciences-iart-bear-day-2013-06-03", "https://www.nasdaq.com/articles/disappointing-1q-earnings-for-iart-analyst-blog-2013-05-10", "https://www.nasdaq.com/articles/product-recall-plagues-integra-analyst-blog-2013-04-11", "https://www.nasdaq.com/articles/integras-second-cobalt-chrome-rod-analyst-blog-2013-03-26", "https://www.nasdaq.com/articles/fda-nod-for-integras-extremity-offer-analyst-blog-2013-03-22", "https://www.nasdaq.com/articles/integra-strong-on-balanced-growth-analyst-blog-2013-02-26", "https://www.nasdaq.com/articles/accurays-outlook-disappoints-analyst-blog-2013-01-07", "https://www.nasdaq.com/articles/integra-grows-european-portfolio-analyst-blog-2013-06-27", "https://www.nasdaq.com/articles/accuray-misses-ests-loss-widens-analyst-blog-2012-11-09", "https://www.nasdaq.com/articles/fda-clears-accurays-cyberknife-m6-analyst-blog-2012-11-05", "https://www.nasdaq.com/articles/integra-beats-on-eps-misses-rev-analyst-blog-2012-10-29", "https://www.nasdaq.com/articles/accuray-reiterated-at-neutral-analyst-blog-2012-09-24", "https://www.nasdaq.com/articles/accuray-misses-ests-posts-loss-analyst-blog-2012-09-07", "https://www.nasdaq.com/articles/encouraging-2q-for-integra-analyst-blog-2012-07-27", "https://www.nasdaq.com/articles/integras-new-pip-fixation-device-analyst-blog-2012-06-22", "https://www.nasdaq.com/articles/accuray-down-to-underperform-analyst-blog-2012-11-28", "https://www.nasdaq.com/articles/fda-nod-for-integra-spine-analyst-blog-2012-04-20", "https://www.nasdaq.com/articles/integra-expands-in-europe-analyst-blog-2012-03-28", "https://www.nasdaq.com/articles/integra-launches-new-vet-products-analyst-blog-2012-03-21", "https://www.nasdaq.com/articles/integra-beats-on-eps-revs-in-line-analyst-blog-2012-02-24", "https://www.nasdaq.com/articles/integras-new-extremity-offering-analyst-blog-2012-02-10", "https://www.nasdaq.com/articles/integras-prelim-results-disappoint-analyst-blog-2012-01-06", "https://www.nasdaq.com/articles/medical-breakthrough-successful-stem-cell-transplant-sweden-2011-07-08", "https://www.nasdaq.com/articles/integra-beats-ups-eps-guidance-analyst-blog-2012-04-26", "https://www.nasdaq.com/articles/mid-day-update-stocks-pare-modest-early-gains-despite-upbeat-home-sales-2011-05-24", "https://www.nasdaq.com/articles/opening-view-djia-leaves-april-behind-looks-higher-ground-may-2010-05-03", "https://www.nasdaq.com/articles/stocks-downshift-red-earnings-home-sales-data-support-erodes-2011-05-24"], "Content": []}